Rymedi
PrivateLast Round
Series A
Oct 25, 2023
Total Funding Raised
$17M
Company Overview
Rymedi is a healthcare technology company that provides a blockchain-secured data exchange platform for diagnostic testing, clinical trials, and occupational health.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Pharma Supply Chain, Data Governance, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rymedi Comparables
Compare Rymedi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Triall | 81% | |
| Chronicled | 76% | |
| Embleema | 76% |
Rymedi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 25, 2023 | ||||
| Debt | May 1, 2020 |
Key People
Founding team and executive leadership
Rymedi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| White Star Capital | Series A |
| Founderville | Seed |
| Catalytic Impact Foundation | Seed |
| Raptor Digital | Series A |
| Blockchange Ventures | Series A |
| RW3 Ventures | Series A |
Rymedi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rymedi's valuation, stock price, and market status.
Is Rymedi a public or private company?
Rymedi is a private company.
What is the current stock price of Rymedi?
Rymedi is a private company with no public stock price. No recent secondary market data is available.
How much is Rymedi worth (valuation)?
Valuation information for Rymedi is not publicly available.
Can I buy Rymedi stock?
Rymedi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rymedi's last funding round?
Rymedi's most recent funding round was Series A on October 25, 2023.
Who are the main investors in Rymedi?
Key investors in Rymedi include White Star Capital, RW3 Ventures.
Will Rymedi IPO soon?
No public IPO plans have been announced for Rymedi.
How can I track Rymedi secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rymedi's secondary market activity and sign up for updates.